Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116958142 | 11695814 | 2 | F | 20151030 | 20151102 | 20151104 | 20160829 | EXP | US-ROCHE-ITM201506IM017701 | ROCHE | 85.28 | YR | F | Y | 65.38000 | KG | 20160829 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
116958142 | 11695814 | 1 | PS | ESBRIET | PIRFENIDONE | 1 | Oral | 2403 MG | 1401364A,3029581 | 22535 | 801 | MG | CAPSULE | TID | |||||
116958142 | 11695814 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Unknown | 17581 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
116958142 | 11695814 | 1 | Idiopathic pulmonary fibrosis |
116958142 | 11695814 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
116958142 | 11695814 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
116958142 | 11695814 | Back pain | |
116958142 | 11695814 | Death | |
116958142 | 11695814 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
116958142 | 11695814 | 1 | 20150416 | 0 |